Drugs normally used to treat cancer could reduce the disfigurements of thousands of children born with life-threatening blood vessel defects, according to research led by Great Ormond Street Hospital (GOSH) and its academic partner, the UCL Great Ormond Street Institute of Child Health (ICH).

Clinical Scientist Beth Hoskins specialises in molecular genetics at GOSH. She analyses DNA tests from patients with rare conditions to test for abnormalities. When not at GOSH, Beth volunteers for GoodGym, a community of runners from all over the UK who work out while helping others.

She has clocked up 1,600 kilometres jogging around her borough carrying out 500 'good deeds', including running every week to see an isolated 64-year-old called Paul.